CLPS Incorporation (CLPS) Competitors

Cardlytics (NASDAQ:CDLX) and CLPS Incorporation (NASDAQ:CLPS) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Do insiders and institutionals hold more shares of CDLX or CLPS?

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 0.2% of CLPS Incorporation shares are held by institutional investors. 4.4% of Cardlytics shares are held by insiders. Comparatively, 58.7% of CLPS Incorporation shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media favor CDLX or CLPS?

In the previous week, Cardlytics had 16 more articles in the media than CLPS Incorporation. MarketBeat recorded 19 mentions for Cardlytics and 3 mentions for CLPS Incorporation. CLPS Incorporation's average media sentiment score of 0.83 beat Cardlytics' score of 0.04 indicating that CLPS Incorporation is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	0 Very Positive mention(s)	1 Positive mention(s)	15 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
CLPS Incorporation	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, CDLX or CLPS?

CLPS Incorporation has lower revenue, but higher earnings than Cardlytics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$293.47M	0.34	-$134.70M	-$6.11	-0.32
CLPS Incorporation	$153.82M	0.22	-$2.33M	N/A	N/A

Do analysts recommend CDLX or CLPS?

Cardlytics currently has a consensus price target of $6.92, suggesting a potential upside of 249.33%. Given Cardlytics' stronger consensus rating and higher possible upside, research analysts clearly believe Cardlytics is more favorable than CLPS Incorporation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.14
CLPS Incorporation	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk & volatility, CDLX or CLPS?

Cardlytics has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500. Comparatively, CLPS Incorporation has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Is CDLX or CLPS more profitable?

CLPS Incorporation has a net margin of 0.00% compared to Cardlytics' net margin of -93.55%. CLPS Incorporation's return on equity of 0.00% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-93.55%	-110.67%	-32.70%
CLPS Incorporation	N/A	N/A	N/A

Does the MarketBeat Community prefer CDLX or CLPS?

Cardlytics received 114 more outperform votes than CLPS Incorporation when rated by MarketBeat users. However, 64.91% of users gave CLPS Incorporation an outperform vote while only 57.25% of users gave Cardlytics an outperform vote.

Company	Underperform	Outperform
Cardlytics	Outperform Votes 225 57.25%	Underperform Votes 168 42.75%
CLPS Incorporation	Outperform Votes 111 64.91%	Underperform Votes 60 35.09%

Summary

Cardlytics beats CLPS Incorporation on 9 of the 16 factors compared between the two stocks.